Identification of antigens presented by MHC for vaccines against tuberculosis

Identification of antigens presented by MHC for vaccines against tuberculosis

Show other versions (1)

Mycobacterium tuberculosis (M.tb) is responsible for more deaths globally than any other pathogen. The only available vaccine, bacillus Calmette-Guérin (BCG), has variable efficacy throughout the world. A more effective vaccine is urgently needed. The immune response against tuberculosis relies, at...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Bettencourt, P, Müller, J, Nicastri, A, Cantillon, D, Madhavan, M, Charles, PD, Fotso, CB, Wittenberg, R, Bull, N, Pinpathomrat, N, Waddell, SJ, Stylianou, E, Hill, AVS, Ternette, N, McShane, H
פורמט:	Journal article
שפה:	English
יצא לאור:	Springer Nature 2020

פריטים דומים

Identification of antigens presented by MHC for vaccines against tuberculosis
מאת: Bettencourt, P, et al.
יצא לאור: (2020)

Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis
מאת: Bettencourt, P, et al.
יצא לאור: (2019)

Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine
מאת: Stylianou, E, et al.
יצא לאור: (2018)

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
מאת: Stylianou, E, et al.
יצא לאור: (2023)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
מאת: Pinpathomrat, N, et al.
יצא לאור: (2021)

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1− CD4+ T cells
מאת: Bull, N, et al.
יצא לאור: (2018)

Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M. tb infection model
מאת: Harrington-Kandt, R, et al.
יצא לאור: (2018)

Vaccines for tuberculosis
מאת: McShane, H
יצא לאור: (2013)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
מאת: Stylianou, E, et al.
יצא לאור: (2019)

Hypoxia inhibits MHC I expression and antigen presentation to escape immune surveillance
מאת: Estephan, H, et al.
יצא לאור: (2025)

Monoclonal antibodies to rat leukocyte surface antigens, MHC antigens, and immunoglobulins.
מאת: Puklavec, M, et al.
יצא לאור: (2001)

Human and Bovine Tuberculosis
מאת: McShane, H
יצא לאור: (2016)

Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
מאת: Purcell, A, et al.
יצא לאור: (2019)

Insights and challenges in tuberculosis vaccine development
מאת: McShane, H
יצא לאור: (2019)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
מאת: McShane, H
יצא לאור: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
מאת: McShane, H
יצא לאור: (2011)

Tuberculosis vaccines: Progress and challenges
מאת: Checkley, A, et al.
יצא לאור: (2011)

Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing.
מאת: Mimura, Y, et al.
יצא לאור: (2007)

Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer identifies potential immunotherapy target antigens
מאת: Ternette, N, et al.
יצא לאור: (2018)

Discrimination between human leukocyte antigen class I-bound and co-purified HIV-derived peptides in immunopeptidomics workflows
מאת: Partridge, T, et al.
יצא לאור: (2018)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
מאת: Griffiths, K, et al.
יצא לאור: (2013)

Local pulmonary immunological biomarkers in tuberculosis
מאת: Morrison, H, et al.
יצא לאור: (2021)

MECHANISM OF MHC-MEDIATED ANTIGEN RECOGNITION BY T-CELLS
מאת: Bowness, P, et al.
יצא לאור: (1993)

The human T lymphocyte receptor complex for antigen and MHC.
מאת: Royer, H, et al.
יצא לאור: (1985)

MHC antigens and cancer: implications for T-cell surveillance.
מאת: Browning, M, et al.
יצא לאור: (1992)

NNAlign_MA; MHC peptidome deconvolution for accurate MHC binding motif characterization and improved T-cell epitope predictions
מאת: Alvarez, B, et al.
יצא לאור: (2019)

The Choice of HLA-Associated Peptide Enrichment and Purification Strategy Affects Peptide Yields and Creates a Bias in Detected Sequence Repertoire
מאת: Nicastri, A, et al.
יצא לאור: (2020)

Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
מאת: Setterblad, N, et al.
יצא לאור: (2004)

Controlled human infection models: is it really feasible to give people tuberculosis?
מאת: McShane, H
יצא לאור: (2020)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
מאת: McShane, H
יצא לאור: (2023)

High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease.
מאת: Pathan, A, et al.
יצא לאור: (2000)

Antibodies and tuberculosis
מאת: Jacobs, A, et al.
יצא לאור: (2016)

Why don’t we have an effective tuberculosis vaccine yet?
מאת: Davenne, T, et al.
יצא לאור: (2016)

Challenges in developing a controlled human tuberculosis challenge model
מאת: Jackson, S, et al.
יצא לאור: (2022)

Clinical testing of tuberculosis vaccine candidates
מאת: Hatherill, M, et al.
יצא לאור: (2016)

MHC-peptide tetramers for the analysis of antigen-specific T cells.
מאת: Sims, S, et al.
יצא לאור: (2010)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
מאת: Poyntz, H, et al.
יצא לאור: (2014)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
מאת: Vermaak, S, et al.
יצא לאור: (2023)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
מאת: Tanner, R, et al.
יצא לאור: (2016)

Direct Identification of Vaccine-Induced HIV-1-Specific MHC Class I Associated Epitopes by Mass Spectrometry
מאת: Ternette, N, et al.
יצא לאור: (2013)